Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-28 | NCT07900867 This Study Will Evaluate the Effect and Safety of 626 in Patients With CLE | Phase 2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 4 | |
| Phase 1/2 | 1 | |
| Phase 2 | 6 | |
| Phase 3 | 7 |
Disease areas by active trials
Ankylosing Spondylitis (3) · Atopic Dermatitis (3) · Asthma (2) · Lupus (SLE) (2) · Colorectal Cancer (1) · COPD (1) · Ulcerative Colitis (1)
Get alerts when Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.